Skip to content
VistaPath

Zimbabwe Rejects ‘One-Sided’ US Health Aid Agreement Because of Data Fears

Health funding illustration
The offered US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has declined a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over the United States' insistence on sensitive biological samples.

This move was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "lopsided".

An official representative has since explained that the US was seeking health data for research and commercial purposes but was not willing to guarantee the benefits from future treatments.

"We must now begin the challenging and unfortunate process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has appealed for continued talks to reach a deal acceptable to both sides so the nation's critical HIV programme can proceed.

Wider Context

This development follows a similar situation in neighbouring Kenya, where a high court blocked a similar health funding agreement following legal challenges were filed about the security of Kenyans' health data.

Since resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance transparency and responsibility.

Based on statements, Sixteen nations in Africa have so far signed similar health pacts, constituting over $18.3bn in committed funds.

Details of the Declined Agreement

This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this collaboration might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported programmes," Tremont added.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.

"Put simply, our country would supply the raw materials for medical research without any assurance that the resulting innovations would be available to our people should a new disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one deals were disrupting frameworks already set up via the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.

"This mechanism is designed to guarantee that when a country contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."

These objections regarding the US deal "must not be interpreted as opposition to America," he added.

"We welcome further discussions with our American counterparts on how future co-operation might be arranged in a manner that respects the sovereignty and dignity of each country."

Medical Community Reaction

Medical experts expressed it understood the government's concerns, but recommended that negotiations must proceed considering a large portion of the nation's Aids initiatives relied on foreign aid.

"In cases where specific concerns arise, including those relating to information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group commented.

This impasse emphasises the ongoing challenges between receiving crucial international aid and protecting local interests in an ever more interconnected world.

The writer

Joy Dawson

A tech strategist with over a decade of experience in digital innovation and business transformation, passionate about simplifying complex tech concepts.

VistaPath

Type to search articles.